Post-Concussion Symptom Scale (PCSS) 

The Post-Concussion Symptom Scale (PCSS) is a 22-item, self-reported checklist that rates concussion symptoms — headache, fogginess, irritability, sleep disturbance, and related somatic, cognitive, emotional, and sleep complaints — on a 0–6 severity scale. It takes 5–10 minutes and is used to track symptom trajectory over time, not to diagnose concussion on its own.

What the PCSS Measures

The PCSS covers four overlapping symptom domains that clinicians managing concussion patients need to watch simultaneously:

• Somatic symptoms — headache, dizziness, nausea, visual disturbance, sensitivity to light and noise
• Cognitive symptoms — feeling mentally "foggy" or "slowed down," difficulty concentrating, difficulty remembering
• Emotional symptoms — irritability, sadness, nervousness, feeling more emotional than usual
• Sleep-related symptoms — drowsiness, sleeping more or less than usual, trouble falling asleep

Each of the 22 items is rated 0 (none) to 6 (severe), and the tool reports two numbers: a total symptom severity score (0–132) and a count of symptoms endorsed. Both matter clinically — a patient can report the same total score with a few severe symptoms or many mild ones, and the pattern often shapes the treatment plan differently than the total alone would suggest.

Administration and Time

The PCSS is self-administered on paper or digitally in about 5–10 minutes. It requires no clinician training to deliver, which is part of why it is so widely embedded in concussion protocols — it can be captured at intake, at each follow-up visit, or between visits without consuming clinical time.

Scoring and Interpretation

There is no single, universally standardized cutoff score that defines "recovered" or "abnormal" on the PCSS. Unlike PHQ-9 or GAD-7, which have well-established severity bands, the PCSS is designed primarily for within-patient tracking: comparing a current score against the patient's own preinjury baseline (when available) or against their own prior post-injury scores to judge whether symptoms are trending down, plateauing, or worsening.

In practice, most concussion protocols treat the PCSS as a trend instrument rather than a threshold instrument:

• A falling total score and falling symptom count across serial administrations generally support ongoing recovery.
• A plateau or rebound — particularly after a period of improvement — is commonly treated as a signal to reassess activity level, screen for a specific symptom driver (headache, vestibular, sleep, mood), or consider referral.
• Persistent elevated symptoms beyond the expected recovery window are one of several factors clinicians weigh when considering a post-concussion syndrome evaluation.

The PCSS is commonly embedded within the SCAT5/SCAT6 sideline and clinic assessment tools, so many clinicians already encounter it as one component of a broader concussion battery rather than as a standalone instrument.

Clinical Use Case

The PCSS is most useful as a serial monitoring tool across the concussion recovery timeline: at initial evaluation, at each in-clinic follow-up, and — increasingly — between visits, where it can catch a symptom spike or plateau before the next scheduled appointment. Because it is quick and low-burden, it is well suited to frequent administration in ways that longer neuropsychological batteries are not.

It is typically used alongside, not instead of, other elements of the concussion workup: cognitive screens, vestibular/ocular-motor screening, and structured clinical interview. It also frequently sits next to condition-specific screens when comorbidities are suspected — headache severity via HIT-6, sleep disruption via PSQI, or mood symptoms via PHQ-9 and GAD-7 — since concussion symptom burden and these comorbidities frequently overlap and complicate recovery.

CPT and Billing Context

The PCSS is a brief self-report checklist, and it is generally not billed as a standalone CPT code. In most protocols it is captured as part of the evaluation and management (E/M) visit, or — when a technician administers and scores it as part of a larger structured battery — it may be folded into the broader neurobehavioral or psychological testing codes rather than billed on its own.

Where the PCSS becomes commercially relevant is in between-visit monitoring. When a practice captures PCSS data on a recurring basis outside the office visit — say, weekly during an active recovery period — that data collection and clinician review is the kind of activity Remote Therapeutic Monitoring (RTM) codes were built to reimburse, particularly the device/monitoring supply code 98978 and the treatment management codes 98980 and 98981. See RTM for cognitive-behavioral monitoring for how a symptom-tracking instrument like the PCSS fits into an RTM billing workflow, and CMS's general guidance on RTM services for current program requirements.

Where PCSS Sits in the Kavera Protocol

Within the Kavera Concussion module, the PCSS is typically administered as one of the recurring instruments patients complete between office visits, alongside condition-relevant screens for headache, sleep, and mood when clinically indicated. Serial PCSS results feed the same between-visit dataset that supports RTM documentation, so a clinician can see the symptom trend at a glance rather than reconstructing it from scattered paper checklists at each visit.

How Kavera Handles This

PCSS is the weekly digital check-in at the heart of the Concussion module. It goes to the patient's phone every week, scores in four symptom clusters, and plots against the first-visit baseline. That weekly record, plus brain training, is the device data behind 98978, and the clinician review time behind 98979/98980. Self-Serve practices run this with their own staff. On Managed, Juliet Mott's team runs it and bills it under your credentials.

FAQ

Is the PCSS a diagnostic test for concussion?

No. The PCSS measures self-reported symptom severity and is used for tracking, not diagnosis. Concussion diagnosis relies on clinical evaluation, history, and, when indicated, additional assessment tools.

What is considered a "good" PCSS score?

There is no single validated cutoff. Interpretation is generally relative — comparing a patient's current score to their own preinjury baseline or prior post-injury scores, with a falling trend generally viewed favorably.

How often should the PCSS be administered?

Frequency varies by protocol and clinical judgment. Many concussion-care practices administer it at each visit and, increasingly, at set intervals between visits to catch changes early.

Can the PCSS be billed under a specific CPT code?

Generally not as a standalone code. It is typically bundled into the E/M visit or, when administered by a technician as part of a larger battery, into the broader test administration codes. When used for structured between-visit monitoring, it can support RTM billing documentation — see RTM 98978.

Does a stable PCSS score always mean full recovery?

Not necessarily. Some patients under-report symptoms, and a stable score should be interpreted alongside cognitive testing, functional status, and clinical exam rather than in isolation.